Accounts Receivables - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Accounts Receivables Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Accounts Receivables
ÂŁ7.3B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
4%
A
AstraZeneca PLC
NASDAQ:AZN
Accounts Receivables
$11B
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
4%
Indivior PLC
LSE:INDV
Accounts Receivables
$259m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
4%
Hikma Pharmaceuticals PLC
LSE:HIK
Accounts Receivables
$937m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
10%
Allergy Therapeutics PLC
LSE:AGY
Accounts Receivables
ÂŁ9.9m
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
2%
Dechra Pharmaceuticals PLC
LSE:DPH
Accounts Receivables
ÂŁ161.9m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
19%

See Also

What is GlaxoSmithKline PLC's Accounts Receivables?
Accounts Receivables
7.3B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Accounts Receivables amounts to 7.3B GBP.

What is GlaxoSmithKline PLC's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
4%

Over the last year, the Accounts Receivables growth was 7%. The average annual Accounts Receivables growth rates for GlaxoSmithKline PLC have been 2% over the past three years , 1% over the past five years , and 4% over the past ten years .

Back to Top